Entering text into the input field will update the search result below

Galena to receive EU patent for breast-cancer vaccine

Aug. 21, 2013 8:32 AM ETSELLAS Life Sciences Group, Inc. (SLS) StockSLSBy: Yigal Grayeff, SA News Editor
  • The European Patent Office notifies Galena Biopharma (GALE +7.6%) that it intends to grant a patent that covers the use of the company's NeuVax drug as a vaccine for the prevention of relapse in breast-cancer patients.
  • The patent is due to expire in April 2028. (PR)

Recommended For You

More Trending News

About SLS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SLS--
SELLAS Life Sciences Group, Inc.